0000950170-24-037399.txt : 20240327
0000950170-24-037399.hdr.sgml : 20240327
20240327174032
ACCESSION NUMBER: 0000950170-24-037399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240327
DATE AS OF CHANGE: 20240327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iwicki Mark T
CENTRAL INDEX KEY: 0001415537
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 24792345
MAIL ADDRESS:
STREET 1: 84 WATERFORD DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Q32 Bio Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-999-0232
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Homology Medicines, Inc.
DATE OF NAME CHANGE: 20151228
4
1
ownership.xml
4
X0508
4
2024-03-25
0001661998
Q32 Bio Inc.
QTTB
0001415537
Iwicki Mark T
Q32 BIO INC.
830 WINTER STREET
WALTHAM
MA
02451
true
false
false
false
false
Stock Option (Right to Buy)
16.82
2024-03-25
4
A
false
25534
0.00
A
2034-03-24
Common Stock
25534
25534
D
One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Eric Bell, Attorney-in-Fact
2024-03-27